“We are in very scary times.” — Michal Elovitz, MD, a Pennsylvania maternal-fetal medicine specialist, discussing the American Board of Obstetricians and Gynecologists’ decision to make its board certification exam virtual this year in part due to safety concerns after the overturning of Roe v. Wade.
“I thought it was the extreme act of courage, bravery, love, and kindness.” — Aji Djamali, MD, a transplant nephrologist at Maine Medical Center, about his decision to become a kidney donor last month.
“It’s a disease that a lot of clinicians aren’t aware of, besides plastic surgeons.” — Connor Kinslow, MD, of Columbia University, on the unexpectedly higher rate of breast implant-related lymphoma detected in a recent study.
“Then take it to the next level. Find out what may be hiding.” — R. Theodore Smith, MD, PhD, of Mount Sinai Health System, on the future possibility of relatively inexpensive retinal cameras that could help clinicians identify high-risk cardiovascular disease in patients with subretinal drusenoid deposits.
“Neurobehavior belongs at the table when it comes to evaluating preterm infants in the NICU.” — Elisabeth McGowan, MD, of Brown Alpert Medical School in Rhode Island, on her group’s research showing that neonatal neurobehavioral patterns can predict motor and cognitive outcomes in toddlerhood.
“From a clinical point of view, it is important to also consider non-pharmacological treatments for insomnia disorder.” — Andrea Cipriani, MD, PhD, of the University of Oxford in England, on how commonly used insomnia pharmacological treatments are often overused and poorly tolerated.